Identity
- Trade Name
- CYT5F-SI FDA UDI
- Generic Name
- Cell-imaging microplate reader IVD FDA UDI
- Device Name
- Cell Imaging Multi-Mode Reader FDA UDI
- Model / Reference
- CYT5F-SI FDA UDI
- Description
- Cell Imaging Multi-Mode Reader FDA UDI
Identifiers
- Primary DI / UDI-DI
- 05700574034399 FDA UDI
- FDA Product Code
- JJQ FDA UDI
- GMDN Term
- Cell-imaging microplate reader IVD FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 862.2300 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Cell-imaging microplate reader IVD
Cyt5f-Si by Agilent Technologies Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Cell-imaging microplate reader IVD.
- C10PW-SI — Agilent Technologies Inc. · Class I
- CYT5FAV-SI — Agilent Technologies Inc. · Class I
- CYT5MFV-SI — Agilent Technologies Inc. · Class I
- CYT5M-SI — Agilent Technologies Inc. · Class I
- CYT5PW-SI — Agilent Technologies Inc. · Class I
- CYT5FW-SI — Agilent Technologies Inc. · Class I
- CYT5FA-SI — Agilent Technologies Inc. · Class I
- CYT5FAW-SI — Agilent Technologies Inc. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Agilent Technologies Inc.
Sources (1)
- FDA UDI be3e0744-5466-4f4e-b659-0e8e1ad4077b 35 fields · synced Jun 6, 2026